Transfusion‐related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012

Citations Over TimeTop 10% of 2014 papers

Abstract

Adverse transfusion reaction rates from the NHSN Hemovigilance Module in the United States are comparable to early hemovigilance reporting from other countries. Although severe reactions are infrequent, the numbers of transfusion reactions in US hospitals suggest that interventions to prevent these reactions are important for patient safety. Further investigation is needed to understand the apparent increased risk of reactions from apheresis-derived blood components. Comprehensive evaluation, including data validation, is important to continued refinement of the module.

Related Papers

• → Prepooled cryoprecipltate for treatment of hemophilia A*(1983)5 cited
• Clinical application of cryoprecipitate(2011)
• Clinical Application of Cryoprecipitate in Patients with Severe Trauma and Operative Trauma(2006)
• Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
• → Genentech taps Affimed’s antibodies(2018)